Group One Trading
GBT

Group One Trading’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Group One Trading’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-115,500
Closed -$7.87M – 8530
2022
Q3 		$7.87M Buy
115,500
+82,000
+245% +$4.52M 0.02% 872
2022
Q2 		$1.07M Sell
33,500
-13,000
-28% -$381K ﹤0.01% 2689
2022
Q1 		$1.61M Sell
46,500
-100
-0.2% -$2.99K ﹤0.01% 2613
2021
Q4 		$1.36M Buy
46,600
+3,600
+8% +$112K ﹤0.01% 3017
2021
Q3 		$1.1M Sell
43,000
-33,900
-44% -$996K ﹤0.01% 3321
2021
Q2 		$2.69M Buy
76,900
+25,200
+49% +$984K ﹤0.01% 2332
2021
Q1 		$2.11M Sell
51,700
-18,100
-26% -$832K ﹤0.01% 2406
2020
Q4 		$3.02M Buy
69,800
+29,100
+71% +$1.43M 0.01% 1691
2020
Q3 		$2.24M Buy
40,700
+5,900
+17% +$375K 0.01% 1505
2020
Q2 		$2.2M Sell
34,800
-25,900
-43% -$1.78M 0.01% 1406
2020
Q1 		$3.1M Sell
60,700
-155,200
-72% -$10.4M 0.03% 778
2019
Q4 		$17.2M Buy
215,900
+47,600
+28% +$2.82M 0.12% 188
2019
Q3 		$8.17M Buy
168,300
+79,100
+89% +$4.12M 0.07% 353
2019
Q2 		$4.69M Sell
89,200
-2,800
-3% -$161K 0.04% 551
2019
Q1 		$4.87M Buy
92,000
+51,500
+127% +$2.53M 0.05% 439
2018
Q4 		$1.66M Sell
40,500
-83,900
-67% -$3.14M 0.01% 1148
2018
Q3 		$4.73M Sell
124,400
-80,800
-39% -$3.58M 0.04% 619
2018
Q2 		$9.28M Buy
205,200
+152,100
+286% +$6.93M 0.08% 270
2018
Q1 		$2.56M Buy
53,100
+16,700
+46% +$931K 0.03% 831
2017
Q4 		$1.43M Buy
36,400
+27,500
+309% +$1.03M 0.01% 1422
2017
Q3 		$276K Sell
8,900
-4,000
-31% -$112K ﹤0.01% 2527
2017
Q2 		$353K Sell
12,900
-18,300
-59% -$545K ﹤0.01% 2215
2017
Q1 		$1.15M Buy
31,200
+30,200
+3,020% +$761K 0.01% 1248
2016
Q4 		$14K Sell
1,000
-3,900
-80% -$68.5K ﹤0.01% 3850
2016
Q3 		$113K Sell
4,900
-2,500
-34% -$47.6K ﹤0.01% 2861
2016
Q2 		$123K Buy
7,400
+7,200
+3,600% +$145K ﹤0.01% 2724
2016
Q1 		$3K Buy
+200
New +$3.55K ﹤0.01% 4328

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Group One Trading's GBT Position: Q2 2022 in Review

Group One Trading sold out of Global Blood Therapeutics, Inc. (GBT) in Q2 2022, closing a stake of 9,656 shares — an estimated $283K sold.

Group One Trading first reported a position in GBT in Q1 2016 and held it in 18 quarters. The position peaked at $5.54M in Q4 2020. 195 funds tracked by Wall St. Rank hold GBT as of Q2 2022.

  • Group One Trading reported no remaining Global Blood Therapeutics, Inc. position as of Q2 2022 after selling out during the quarter.
  • Group One Trading sold 9,656 Global Blood Therapeutics, Inc. shares in Q2 2022, an estimated $283K.
  • Group One Trading first reported a position in Global Blood Therapeutics, Inc. in Q1 2016 and held it in 18 quarters.
  • Group One Trading's Global Blood Therapeutics, Inc. position peaked at $5.54M in Q4 2020.
  • 195 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2022.

Based on Group One Trading's 13F filing for Q2 2022, filed 11 Aug 2022.